Medicine guide

OMJJARA 150 mg

As listed in the register: OMJJARA 150 mg, comprimé pelliculé

· comprimé pelliculé

  • Prescription only
Made by
GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Details

Made byGLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
Active substanceDichlorhydrate De Momélotinib
Formcomprimé pelliculé
Routeorale
Dispensing (as stated by the register)médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription hospitalière · liste I · prescription réservée aux médecins compétents en maladie du sang
MarketedYes, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/23/1782
Name in the registerOMJJARA 150 mg, comprimé pelliculé
Packsflacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)
CIS68004140
CIP133400930282731

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.